Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Changes in Stockholders' Equity (Unaudited)

v3.22.1
Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock - Number of Shares, Shares Issued
Common Stock - Number of Shares, Treasury Shares
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Balance at beginning of period at Dec. 31, 2020 $ 577,044 $ 33 $ (119,046) $ 578,360 $ 3,076 $ 114,621
Beginning balance, shares issued (shares) at Dec. 31, 2020   33,560,801        
Beginning balance, treasury stock (shares) at Dec. 31, 2020     (2,842,966)      
Beginning balance, shares outstanding (shares) at Dec. 31, 2020   30,717,835        
Restricted stock awards, net of forfeitures (shares)   24,380        
Share-based compensation expense 598     598    
Restricted stock surrendered due to employee tax liability (95)   $ (95)      
Restricted stock surrendered due to employee tax liability (shares)   (4,682) (4,682)      
Repurchase of common stock (946)   $ (946)      
Repurchase of common stock (shares)   (55,000) (55,000)      
Cash dividends declared (common stock, $0.10/share, $0.22/share) (3,069)         (3,069)
Net income 16,659         16,659
Change in unrealized gain (loss) on securities available for sale, net of income taxes (8,369)       (8,369)  
Balance at end of period at Mar. 31, 2021 581,822 $ 33 $ (120,087) 578,958 (5,293) 128,211
Ending balance, shares issued (shares) at Mar. 31, 2021   33,585,181        
Ending balance, treasury stock (shares) at Mar. 31, 2021     (2,902,648)      
Ending balance, shares outstanding (shares) at Mar. 31, 2021   30,682,533        
Balance at beginning of period at Dec. 31, 2021 $ 643,417 $ 33 $ (125,753) 580,796 (8,443) 196,784
Beginning balance, shares issued (shares) at Dec. 31, 2021   33,603,839        
Beginning balance, treasury stock (shares) at Dec. 31, 2021 (3,196,578)   (3,196,578)      
Beginning balance, shares outstanding (shares) at Dec. 31, 2021   30,407,261        
Restricted stock awards, net of forfeitures (shares)   66,358        
Share-based compensation expense $ 541     541    
Restricted stock surrendered due to employee tax liability (134)   $ (134)      
Restricted stock surrendered due to employee tax liability (shares)   (5,161) (5,161)      
Cash dividends declared (common stock, $0.10/share, $0.22/share) (6,691)         (6,691)
Net income 20,695         20,695
Change in unrealized gain (loss) on securities available for sale, net of income taxes (36,376)       (36,376)  
Balance at end of period at Mar. 31, 2022 $ 621,452 $ 33 $ (125,887) $ 581,337 $ (44,819) $ 210,788
Ending balance, shares issued (shares) at Mar. 31, 2022   33,670,197        
Ending balance, treasury stock (shares) at Mar. 31, 2022 (3,201,739)   (3,201,739)      
Ending balance, shares outstanding (shares) at Mar. 31, 2022   30,468,458